Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
US11291644B2 · kind B2 · utility
0Cited by
71References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2013 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | Mar 15, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The described invention provides methods for treating pulmonary cancer in a subject, by administering to the subject by inhalation a composition of inhalational lipid cisplatin (ILC) comprising a lipid-complexed cisplatin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.